FRI0164 Local tuberculosis incidence affects the rate of positive conversion in the quantiferon®-tb gold test among patients receiving infliximab or ct-p13 therapy

@inproceedings{Yoo2013FRI0164LT,
  title={FRI0164 Local tuberculosis incidence affects the rate of positive conversion in the quantiferon®-tb gold test among patients receiving infliximab or ct-p13 therapy},
  author={Dae-Hyun Yoo and Sergii Shevchuk and Edgar Ramiterre and Volodymyr S. Kovalenko and Michael Tee and Edgardo Tobias Arteaga and Lucas. Olaz{\'a}bal and Asta Baranauskaitė and Loreta Bukauskienė and Mie Jin Lim and Youn-Hyung Lee and Simona Rednic and Chul Ahn and Ho Ung Kim and Won Hark Park},
  year={2013}
}
Background Treatment with an anti-TNF agent can increase the risk of tuberculosis (TB) by reactivation of latent tuberculosis infection (LTBI) or new infection. Objectives To identify the risk of positive conversion in the QuantiFERON®-TB Gold in-tube (QTF) test in rheumatoid arthritis (RA) and ankylosing spondylitis (AS) patients receiving infliximab (INX) or CT-P13, an INX biosimilar, in 15 countries with various TB incidences Methods Of 856 enrolled subjects, 501 patients (373 RA in 14… CONTINUE READING